Clinical Trial Update: Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial from the Ottawa Hospital Research Institute is evaluating whether granulocyte colony-stimulating factor (G-CSF) can be omitted in ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Early-stage Breast Cancer | Phase 4 | Status: RECRUITING